Intracellular Kinase Inhibitors Selected from Combinatorial Libraries of Designed Ankyrin Repeat Proteins*

  1. Andreas Plückthun
  1. Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, Zürich CH-8057, Switzerland
  1. ¶ To whom correspondence may be addressed. Tel.: 41-44-635-55-03; Fax: 41-44-635-57-12; E-mail: pforrer{at}bioc.unizh.ch. ∥ To whom correspondence may be addressed. Tel.: 41-44-635-55-70; Fax: 41-44-635-57-12; E-mail: plueckthun{at}bioc.unizh.ch.

Abstract

The specific intracellular inhibition of protein activity at the protein level allows the determination of protein function in the cellular context. We demonstrate here the use of designed ankyrin repeat proteins as tailor-made intracellular kinase inhibitors. The target was aminoglycoside phosphotransferase (3′)-IIIa (APH), which mediates resistance to aminoglycoside antibiotics in pathogenic bacteria and shares structural homology with eukaryotic protein kinases. Combining a selection and screening approach, we isolated 198 potential APH inhibitors from highly diverse combinatorial libraries of designed ankyrin repeat proteins. A detailed analysis of several inhibitors revealed that they bind APH with high specificity and with affinities down to the subnanomolar range. In vitro, the most potent inhibitors showed complete enzyme inhibition, and in vivo, a phenotype comparable with the gene knockout was observed, fully restoring antibiotic sensitivity in resistant bacteria. These results underline the great potential of designed ankyrin repeat proteins for modulation of intracellular protein function.

  • Received February 15, 2005.
  • Revision received April 25, 2005.
Table of Contents

Submit your work to JBC.

You'll be in good company.